Collaborative Success Strategies for Biopharm Companies

Hydrogels, drug-eluting contact lenses, and other implant technologies show real promise.

In this episode, Hanns-Christian Mahler from ten23 Health chats about the advances in fill/finish.

The partnership was formed in September 2024 in response to increasing demand for aseptic filling technologies and processes.

In this episode fo the Drug Solutions Podcast, etherna’s vice-president of Technology and Innovation, Stefaan De Koker, discusses the merits and challenges of using mRNA as the foundation for therapeutics in oncology as well as for vaccines.

The new building expands on the company’s supply chain solutions for biologics and temperature-sensitive pharmaceuticals.

Prokaryotics will gain worldwide rights to develop, manufacture, and commercialize NAB741, a non-bioactive polymyxin designed to increase permeability of the outer membrane of Gram-negative bacteria.